Optimal HIV testing and earlier care: The way forward in Europe

HIV Medicine

Volumn 9, Issue SUPPL. 2, 2008, Pages 1-5

  Coenen, T ^a   Lundgren, J ^b   Lazarus, Jeffrey V ^c   Matic, S ^c  

^a National Institute for STI and AIDS Control in the Netherlands   (Netherlands)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Europe; HIV; Optimal testing

Indexed keywords

ANTIRETROVIRUS AGENT;

ADVISORY COMMITTEE; AIDS KNOWLEDGE AND ATTITUDES SURVEY; AWARENESS; EARLY DIAGNOSIS; EARLY INTERVENTION; EDITORIAL; EUROPE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTRAVENOUS DRUG ABUSE; MASS SCREENING; MORBIDITY; MORTALITY; PATIENT CARE; PATIENT COUNSELING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; SEXUAL BEHAVIOR; TOTAL QUALITY MANAGEMENT; VIRUS TRANSMISSION;

AIDS SERODIAGNOSIS; EUROPE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MANDATORY TESTING; WORLD HEALTH ORGANIZATION;

EID: 44949262033     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2008.00583.x     Document Type: Editorial

References (39)

1. UNAIDS. Aids epidemic update. http://data.unaids.org/pub/EPISlides/2007/ 2007_epiupdate_en.pdf 2007.
2. HIV in Europe. http://www.hiveurope2007.eu/index.html 2007.
3. Bartlett JG, Mayer KH. Routine opt-out HIV testing: Rationale for the Consensus Conference and this supplement. Clin Infect Dis 2007; 45: S203-S205.
4. Centers for Disease Control and Prevention. Revised guidelines for HIV counselling, testing, and referral. Morbid Mortal Weekly Rep Recomm Rep 2001; 50: 1-57.
5. Centers for Disease Control and Prevention. Revised recommendations for HIV of adults, adolescent and pregnant women in heath care settings. Morbid Mortal Weekly Rep 2006a; 50: 1-16.
6. Dubois-Arber F, Paccaud F. Assessing AIDS/HIV prevention: What do we know in Europe? Soz Praventivmed 1994; 39 (Suppl. 1): S3-S13.
7. Pollak M, Dür W, Vincineau M et al. Evaluating AIDS prevention for men having sex with men: The west European experience. Soz Praventivmed 1994; 39 (Suppl. 1): S47-S60.
8. Rezza G, Rota MC, Buning E et al. Assessing HIV prevention among injecting drug users in European Community countries: A review. Soz Praventivmed 1994; 39 (Suppl. 1): S61-S78.
9. Bellingham K, Gillies P. Evaluation of an AIDS education programme for young adults. J Epidemiol Community Health 1993; 47: 134-138.
10. Klee H, Faugier J, Hayes C, Morris J. Risk reduction among injecting drug users: Changes in the sharing of injecting equipment and in condom use. AIDS Care 1991; 3: 63-73.
11. Hamers FF, Downs AM. The changing face of the HIV epidemic in western Europe: What are the implications for public health policies? Lancet 2004; 364: 83-94. (Review).
12. Sabin CA, Smith CJ, Gumley H et al. Late presenters in the era of highly active antiretroviral therapy: Uptake of and responses to antiretroviral therapy. AIDS 2004; 18: 2145-2151.
13. Klein D, Hurley LB, Merrill D et al. Review of medical encounters in the 5 years before a diagnosis of HIV-1 infection: Implications for early detection. J Acquir Immune Defic Syndr 2003; 32: 257-275.
14. Manavi K, McMillan A, Ogilvie M et al. Heterosexual men and women with HIV test positive at a later stage of infection than homo- or bisexual men. Int J STD AIDS 2004; 15: 811-814.
15. Krentz HB, Auld MC, Gill MJ. The high cost of medical care for patients who present late (CD4<200 cells/μL) with HIV infection. HIV Med 2004; 5: 93-98.
16. Girardi E, Aloisi MS, Arici C et al. Delayed presentation and late testing for HIV: Demographic and behavioural risk factors in a multicenter study in Italy. J Acquir Immune Defic Syndr 2004; 36: 951-959.
17. Sullivan AK, Curtis H, Sabin CA et al. National review of newly diagnosed HIV infections. BMJ 2005; 330: 1301-1302.
18. Louis C, Ivers LC, Smith Fawzi MC, Freedberg KA, Castro A. Late presentation for HIV care in central Haiti: Factors limiting access to care. AIDS Care 2007; 19: 487-491.
19. Boffito M, Bonora S, Sinicco A et al. Treating advanced HIV infection. J Acquir Immune Defic Syndr 2003; 34: 344-345.
20. Centers for Disease Control and Prevention. Missed Opportunities for Earlier Diagnosis of HIV Infection - South Carolina, 1997-2005. Morbid Mortal Weekly Rep 2006b; 55: 1269-1272.
21. Hocking JS, Rodger AJ, Rhodes DG, Crofts N. Late presentation of HIV infection associated with prolonged survival following AIDS diagnosis - characteristics of individuals. Int J STD AIDS 2000; 11: 503-508.
22. Couturier E, Schwoebel V, Michon C et al. Determinants of delayed diagnosis of HIV infection in France, 1993-1995. AIDS 1998; 12: 795-800.
23. Longo B, Pezzotti P, Boros S, Urciuoli R, Rezza G. Increasing proportion of late testers among AIDS cases in Italy, 1996-2002. AIDS Care 2005; 17: 834-841.
24. Chadborn TR, Delpech VC, Sabin CA, Sinka K, Evans BG. The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000-2004). AIDS 2006; 20: 2371-2379.
25. Rosinska M. Current trends in HIV/AIDS epidemiology in Poland, 1999-2004. Euro Surveill 2006; 11: 94-97.
26. Castilla J, Sobrino P, De La Fuente L et al. Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence. AIDS 2002; 16: 1945-1951.
27. Girardi E, Sabin CA, d'Arminio Monforte A. Late diagnosis of HIV infection: Epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr 2007; 46 (Suppl. 1): S3-S8.
28. World Health Organization. Sexually transmitted infections/HIV/AIDS. Available at: http://www.euro.who.int/aids
29. European AIDS Treatment Group. Living with HIV. Travel restrictions. http://www.eatg.org/pages/article.php?id=1080 2007.
30. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006; 20: 1447-1450.
31. Porco TC, Martin JN, Page-Shafer KA et al. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS 2004; 18: 81-88.
32. UNAIDS/WHO. Progress on Implementing the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia. Copenhagen: WHO Regional Office for Europe, 2008.
33. Walensky RP, Weinstein MC, Kimmel AD et al. Routine human immunodeficiency virus testing: An economic evaluation of current guidelines. Am J Med 2005; 118: 292-300.
34. Paltiel AD, Weinstein MC, Kimmel AD et al. Expanded screening for HIV in the United States - an analysis of cost-effectiveness. N Engl J Med 2005; 352: 586-595.
35. Holtgrave D. Costs and consequences of the US Centers for Disease Control and Prevention's recommendations for opt-out HIV testing. PLOS Med 2007; 4: E194.
36. Centers for Disease Control and Prevention. HIV testing among pregnant women - United States and Canada, 1998-2001. Morbid Mortal Weekly Rep 2002; 51: 1013-1016.
37. British Association for Sexual Health and HIV (BASHH). United Kingdom national guidelines on HIV testing. http://www.bashh.org/guidelines/2006/ hiv_testing_june06.pdf 2006.
38. European AIDS Clinical Society (EACS). Optimal HIV testing and earlier care in Europe. Presented at the 11th European AIDS Conference, Madrid, Spain, October 24-27, 2007. http://www.multiwebcast.com/eacs/2007/11th
39. UNAIDS. Aids epidemic update. http://www.unaids.ru/files/file/ 06-Eastern_Europe_and_Central_Asia_2006_EpiUpdate_eng.pdf 2006.